Rheumatoid Arthritis Quiz

Rheumatoid Arthritis (RA): Practice Guide for Exam-Style Questions

Rheumatoid Arthritis (RA) is a systemic, inflammatory autoimmune disease that primarily affects the synovial joints. Understanding its core concepts, from pathophysiology to treatment, is crucial for clinical assessments and exams. This guide breaks down the essential information into digestible sections to help you master the topic.

Core Pathophysiology: The Autoimmune Attack

At its heart, RA involves the immune system mistakenly attacking the synovium, the membrane lining the joints. This triggers a chronic inflammatory cascade, leading to synovial hypertrophy and the formation of an aggressive tissue layer called pannus, which erodes cartilage and bone.

Hallmark Clinical Presentation

The classic presentation of RA is a symmetrical, inflammatory polyarthritis. It typically affects the small joints of the hands (metacarpophalangeal and proximal interphalangeal joints) and feet. Prolonged morning stiffness, often lasting over an hour, is a key diagnostic clue.

Differentiating RA from Osteoarthritis (OA)

Distinguishing RA from OA is a common exam question. RA is inflammatory and autoimmune, with systemic features, while OA is a degenerative “wear-and-tear” condition. RA affects MCP and PIP joints, whereas OA typically involves DIP and PIP joints. Morning stiffness in OA is usually brief (under 30 minutes).

Key Serological Markers: RF vs. Anti-CCP

Two main antibodies are tested for RA. Rheumatoid Factor (RF) is sensitive but not specific, as it can be positive in other conditions. Anti-cyclic citrullinated peptide (anti-CCP) antibodies are highly specific for RA (around 95%) and are associated with more aggressive disease.

Pharmacological Management: The DMARD Strategy

Disease-Modifying Antirheumatic Drugs (DMARDs) are the cornerstone of RA treatment. Their main goal is to slow or halt disease progression and prevent joint destruction. Methotrexate is the most common first-line conventional DMARD.

Understanding Biologic Agents

Biologic DMARDs are a more advanced class of drugs that target specific parts of the inflammatory pathway. For instance, TNF-alpha inhibitors block a key cytokine that drives inflammation. These are used for moderate to severe RA, often when conventional DMARDs are insufficient.

Recognizing Extra-Articular Manifestations

RA is a systemic disease. It’s vital to know its potential effects outside the joints. These include rheumatoid nodules, interstitial lung disease, pericarditis, scleritis in the eyes, and vasculitis. Recognizing these shows an understanding of the disease’s full scope.

Classic Radiographic Findings and Deformities

Long-standing RA leads to characteristic X-ray findings and physical deformities. Radiographs may show periarticular osteopenia, joint space narrowing, and bony erosions. Classic hand deformities include ulnar deviation, Boutonnière deformity, and swan-neck deformity.

Commonly Tested Early Symptoms of RA

• Symmetrical inflammatory arthritis affecting three or more joints.
• Prolonged morning stiffness lasting more than 30 minutes (often hours).
• Pain and swelling in small joints of the hands and feet (MCPs, PIPs, MTPs).
• Constitutional symptoms such as fatigue, malaise, and low-grade fever.
• The presence of a “boggy” feel on joint palpation due to synovial inflammation.

Goals of Modern RA Treatment

• Achieve and maintain a state of clinical remission or low disease activity.
• Prevent or significantly slow the progression of structural joint damage.
• Preserve physical function, enabling normal daily activities and work.
• Control pain and inflammation to improve overall quality of life.
• Manage and reduce the risk of systemic comorbidities like cardiovascular disease.

Key Takeaways

• RA is a systemic autoimmune disease characterized by symmetrical, inflammatory polyarthritis.
• Morning stiffness lasting over an hour is a hallmark symptom.
• Anti-CCP antibodies are highly specific for RA diagnosis and prognosis.
• Treatment with DMARDs aims to prevent joint destruction, not just relieve symptoms.
• Be aware of extra-articular manifestations affecting the lungs, heart, and skin.

This content is for informational and educational purposes only and does not constitute medical advice. It is intended to help students and professionals review key concepts related to the diagnosis, pathophysiology, and treatment principles of Rheumatoid Arthritis.